PRINCIPAL FINANCIAL GROUP INC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1126328 DES MOINES, IA

Position in ARQT

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$3,977,539

+$3,804,979 QoQ

Shares Held

168,826

+809.9% QoQ

Ownership

0.135%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. ARQT ranks #45 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	896,397	$205,032,885
2	VRTX	Vertex Pharmaceuticals Inc / Ma	426,523	$190,459,579
3	INSM	INSMED Inc	916,464	$149,860,192
4	BBIO	BridgeBio Pharma, Inc.	1,330,415	$98,796,617
5	REGN	Regeneron Pharmaceuticals, Inc.	120,425	$93,045,171
6	GPCR	Structure Therapeutics Inc.	1,753,764	$84,531,424
7	CYTK	Cytokinetics Inc	1,093,485	$72,071,595
8	AXSM	Axsome Therapeutics, Inc.	350,488	$59,239,481

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,977,539	168,826	+809.9%	Shares	Defined	2026-05-04
2024-06-30	$172,560	18,555	-3.0%	Shares	Defined	2024-07-29
2024-03-31	$189,528	19,125	+3.8%	Shares	Defined	2024-04-29
2023-12-31	$59,496	18,420	+22.1%	Shares	Defined	2024-02-07
2023-09-30	$80,095	15,084	+1.0%	Shares	Defined	2023-11-02
2023-06-30	$142,339	14,936	+11.6%	Shares	Defined	2023-08-07
2023-03-31	$147,213	13,383	-6.8%	Shares	Defined	2023-05-09
2022-12-31	$212,557	14,362	+22.7%	Shares	Defined	2023-02-09
2022-09-30	$223,739	11,708	+5.6%	Shares	Defined	2022-11-09
2022-06-30	$236,263	11,087	+11.4%	Shares	Defined	2022-08-10
2021-09-30	$237,729	9,951	-13.9%	Shares	Defined	2021-11-09
2021-06-30	$315,526	11,562	—	Shares	Defined	2021-08-10
No filing history on record for this holder in this stock.